(Q37189939)

18 August 2017

1 reference

title

Warfarin-induced bleeding complications - clinical presentation and therapeutic options (English)

1 reference

18 August 2017

author name string

Christian J Wiedermann

series ordinal

1

1 reference

18 August 2017

Ingrid Stockner

series ordinal

2

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

122 Suppl 2

1 reference

18 August 2017

page(s)

S13-8

1 reference

Oral anticoagulant treatment: friend or foe in cardiovascular disease?

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

1 reference

7 January 2021

The management of coumarin-induced over-anticoagulation Annotation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Emergency reversal of anticoagulation after intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Guidelines on oral anticoagulation (warfarin): third edition--2005 update

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Urgent reversal of warfarin with prothrombin complex concentrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

The headache over warfarin in British neurosurgical intensive care units: a national survey of current practice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2808%2970004-5

7 January 2021

10.1016/S0049-3848(08)70004-5

Identifiers

DOI

1 reference

18 August 2017

1 reference